Newly Diagnosed Multiple Myeloma Clinical Trials EU — 9 Studies

Filter these 9 trials by phase, country, sponsor and more.

Open in Search →

Study for frail patients with newly diagnosed multiple myeloma treated with Daratumumab in combination with Teclistamab and Talquetamab. Recruiting

2024-520433-76-00 4 2026-01-08
A Phase 2 Multicohort Trial to Further Characterize the Efficacy and Safety of Ciltacabtagene Autoleucel Recruiting

2025-521975-30-00 4 2025-10-03
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Dia … Recruiting

2023-510384-36-00 5 2022-09-13
Belantamab Mafodotin in combination with Daratumumab, Lenalidomide and Dexamethasone for the treatment of patients with newly diagnosed mul … Recruitment ended

2024-515634-32-00 9 2022-03-31
Isa-RVD Study: Phase II, Multi-centre, Single-Arm, Open-Label Study to evaluate the efficacy and safety of the combination regimen Isatuxima … Recruitment ended

2024-512749-18-00 4 2022-03-03
Iberdomide as maintenance therapy after autologous stem cell transplantation in newly diagnosed multiple myeloma patients Recruitment ended

2024-512354-21-00 4 2021-02-22
A phase 1/2, dose and schedule evaluation study to investigate the safety and clinical activity of Belantamab Mafodotin administered in comb … Recruitment ended

2024-515988-55-00 4 2021-02-22
A Clinical trial to compare the combination of Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone versus the combination of Carfilzomib-Lenal … Recruitment ended

2024-513422-38-00 5 2020-09-28
Elotuzumab (E) in Combination with Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) versus KRd prior to and following Autologous Stem Cel … Recruitment ended

2024-515783-31-00 5 2018-08-24

Showing 1–9 of 9 trials